ClearView Healthcare Partners

We’re thrilled to be hitting the road (and the virtual stage!) to meet future talent at this week’s career events. Whether you're exploring opportunities or ready to launch your career, come chat with our team and learn what makes our workplace special. We can’t wait to share insights about our culture, roles, and what it’s like to grow your career with us. Don’t miss the chance to connect! #CareerFair #InfoSession #HiringNow #MeetTheTeam #JoinUs #YourFutureIsInClearView

In today’s increasingly competitive landscape, biopharma manufacturers must strategically prepare for launch. ClearView spoke with 11 industry experts who have launched assets across large pharma and first product launch companies to elucidate the key factors that drive a successful launch. Discover actionable insights and practical recommendations in our white paper that are relevant to setting the foundation for enduring success years after launch: https://lnkd.in/eBHyWP3S   Thank you to our authors from ClearView's Launch & Commercialization Center of Excellence: Jessica B. Lee, Ph.D., Alex Lehrman, Vidhula Pednekar, Annika Rogers   #ClearViewHCP #launch #commercialization #raredisease 

ClearView Healthcare Partners is proud to announce a multi-year deep strategic partnership with Vi, the leader in Enterprise AI for precision targeting and operational excellence in biopharma and healthcare.   ClearView delivers high-resolution strategic guidance, and Vi translates that to precise action. Vi’s extensive behavioral data – capturing 71,000 data points per household and coverage across 96.2% of the US – and its productized powerful data science platform, enable predictive, targeted, data-driven actions across patients and HCP’s powered by ClearView strategy and insights. Together, we’re turning deep market understanding into precisely executed patient activation and real-time HCP omnichannel and operational team triggers that drive prescribing behaviors.   The result: biopharma teams 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗶𝗻𝗴 𝘁𝗿𝗶𝗮𝗹𝘀 𝗯𝘆 𝟱𝟬%+, 𝗱𝗿𝗶𝘃𝗶𝗻𝗴 𝟯𝟬%+ 𝘀𝗰𝗿𝗶𝗽𝘁 𝗹𝗶𝗳𝘁, 𝗮𝗻𝗱 𝘀𝘂𝗿𝗳𝗮𝗰𝗶𝗻𝗴 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗼𝘁𝗵𝗲𝗿𝘀 𝗺𝗶𝘀𝘀.   Vi and ClearView are already driving value across shared clients, and we’re just getting started. Shoot us a DM if interested to discuss!

Real talk on launch strategy— in this episode of ClearView Convos, Jessica B. Lee, Ph.D. and Alex Lehrman join Sam Ulin to break down what drives a successful therapeutic launch—backed by insights from conversations with seasoned biopharma leaders who are long term clients. No shortcuts here: core launch activities remain essential, but best teams tailor their approach to the asset, the market, and the moment. Emerging technologies like precision targeting can drive best in class effectiveness and efficiency, but must be built on robust fundamentals and specifics of the target market. From building the right teams to leveraging patient advocacy and DTC models, the conversation highlights why bespoke planning, early insights, and strong strategic partnerships are key to launch excellence. To learn more, catch their white paper dropping later this week, or even better, join Jessica B. Lee, Ph.D. in Philly at Fierce Pharma Week (Sept 9-11) as she facilitates the Late Commercialization track. Tune in for the full convo to learn what separates good from great in commercialization: #ClearViewConvos #ClearViewHCP #LaunchExcellence #BiopharmaStrategy

Real talk, one take— that's the ClearView Convos way. In this episode, Sam Ulin, Debbie Zhuang, and Matthew Murphy, Ph.D. dive into platform technology strategy. Companies with innovative technologies need to navigate technical risk and capital constraints while maximizing clinical potential alongside return on investment. Debbie and Matt discuss tradeoffs along that journey, with a focus on risk mitigation and value maximization. We talk about what makes a platform truly stand out, how companies are rethinking their R&D priorities, and how platform technology strategy is evolving in response to funding pressures and regulatory shifts. This is just a glimpse—watch the full episode for the full context and deeper takeaways: https://lnkd.in/etkwmWGS #ClearViewHCP #ClearViewConvos #Platformtherapies

To celebrate our Q2 accomplishments, our Boston, New York, San Francisco and London teams took the opportunity to step outside the office for a day of outdoor team activities, lawn games, and great food! It was a rewarding way to recognize our collective efforts, strengthen connections within each office, and recharge for the exciting work ahead. Grateful for our amazing colleagues and the energy they bring every day. #ClearViewHCP #LifeSciences #Consulting #Q2 #Event

Today on World Hepatitis Day, we join the 2025 call to "Break it Down" -- dismantling the financial, social and systemic barriers to testing, treatment, and awareness for hepatitis. Despite availability of vaccines and treatments, a substantial number of deaths occur worldwide due to complications related to chronic hepatitis (e.g., cirrhosis, liver cancer). ClearView continues to support efforts in patient advocacy and broader access to care. #WorldHepatitisDay #BreakItDown2025 #ClearViewHCP

On #WorldBrainHealthDay, ClearView is proud to champion the 2025 theme: Brain Health for All Ages. As momentum continues to build across neurology, we’re energized by the global effort to advance brain health through advocacy, awareness, education, and innovation. From adolescence to aging, brain health is a lifelong journey—one that benefits from early engagement and continued investment in research and access. In alignment with efforts like the Brain Health Initiative, ClearView remains focused on identifying and supporting solutions that drive meaningful progress. #ClearViewHCP #WorldBrainHealthDay #BrainHealthInitiative

Our 2025 Summer Interns joined us just over a week ago in our New York, San Francisco, and Boston Offices! After completing a week of training and a small case competition, they've officially hit the ground running. Over the coming weeks, they’ll be diving into consulting projects alongside our teams, bringing their passion for innovation, and gaining exposure to the world of life sciences. We're excited to have them on board and look forward to the energy and perspective they'll bring to the team this summer! #Internship2025 #clearviewhcp #YourFutureisinClearView #lifesciencesconsulting

Meeting the moment, as the field evolves, that's what ClearView Convos is all about. Yesterday we recorded a follow-up to Episode 2, diving deeper into evolving vaccine dynamics after RFK Jr. retired all members of the ACIP committee. But when the ACIP nominations dropped last night, we regrouped and filmed a new take first thing this morning so you're hearing insights while they're still hot off the press. Featuring Sam Ulin, Andrew Kang, Kai-Ming Pu, and Seth Berman. Catch both segments, yesterday’s for context and this morning’s for real-time reaction, right here: https://lnkd.in/eVKM8YH6 #ClearViewhcp #ClearViewConvos #Vaccine #FDA